BCL2L10, BCL2 like 10, 10017

N. diseases: 45; N. variants: 1
Disease: Miller Dieker syndrome ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0265219
Disease: Miller Dieker syndrome
Miller Dieker syndrome 		0.030 Biomarker disease BEFREE This study included patients with IPSS lower-risk MDS from the DRAMA (An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome; NCT01400633) and DIVA (A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome; NCT01041846) studies, which were prospective observational studies on the efficacy and safety of decitabine treatment in patients with MDS. 31375393 2019
CUI: C0265219
Disease: Miller Dieker syndrome
Miller Dieker syndrome 		0.030 GeneticVariation disease BEFREE Carriers of the BCL2L10-21Arg variant have a reduced risk of developing t-MN and de novo MDS. 24047476 2014
CUI: C0265219
Disease: Miller Dieker syndrome
Miller Dieker syndrome 		0.030 Biomarker disease BEFREE BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients. 22577154 2012